Recombinant Human LGALS1 (C-6His)

Description

EnkiLife provides the Recombinant Human LGALS1 (C-6His) protein,aslo know as Galectin-1,Gal-1,14 kDa Laminin-Binding Protein,HLBP14,14 kDa Lectin,Beta-Galactoside-Binding Lectin L-14-I,Galaptin,HBL,HPL,Lactose-Binding Lectin 1,Lectin Galactoside-Binding Soluble 1,Putative MAPK-Activating Protein PM12,S-Lac Lectin 1,LGALS1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Galectin-1 is produced by our E.coli expression system and the target gene encoding Ala2-Asp135 is expressed with a 6His tag at the C-terminus.Accession:P09382. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:15.78 KDa. Background:Galectin-1 is a member of growing family of evolutionary conserved animal lectins. Galectin-1 is widely expressed in many cells and tissues. Galectins consists of a Galectin domain and two Beta-galactoside binding domains. Galectin-1 can binds LGALS3BP and interacts with CD2, CD3, CD4, CD7, CD43 and CD45. Galectin-1 may act as an autocrine negative growth factor which regulates apoptosis, cell proliferation and cell differentiation. In addition, Galectin-1 plays improtant roles in immunosuppressive and antiinflammatory properties.